Sign in
Taking people in United StatesNo phase

Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder

Key facts

Who runs it
Stanford University
Where
Palo Alto, United StatesSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
17 Dec 2025
Expected to end
30 Jun 2030
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
  • Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham
Record updated
15 May 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Age 18-75
  • Current DSM-5 diagnosis of moderate to severe AUD (\≥4 diagnostic symptoms)
  • Ability to obtain a Motor Threshold (MT) will be determined during the screening process
  • Has an adequately stable condition and environment to enable attendance at scheduled clinic visits
  • Able to read, understand and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments
  • If on a medication regimen for comorbid symptoms, that regimen will be stable for the duration of the study and patient will be willing to remain on this regimen during the treatment phase
  • Fluency in English

Who cannot take part

  • Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk
  • Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/objected in the head and body within 30 cm of the treatment coil
  • General medical condition, disease or neurological disorder that interferes with the assessments or participation
  • Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder
  • Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold
  • Acute or unstable chronic illness
  • Current or lifetime history of bipolar disorder or psychosis
  • Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen
  • A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study
  • Severe impediment to vision, hearing and/or hand movement, likely to interfere with the ability to follow study protocols
  • Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial is currently available in United States.

  • VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Eileen G Fischer, BSTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.

The 2 groups in the trial

  • Active dTMSTreatment being tested

    Participants will receive 30 sessions of active-dTMS to the dACC/mPFC with the H7 coil, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.

    Treatment: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active

  • Sham dTMSSham treatment, for comparison

    Participants will receive 30 sham dTMS sessions, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.

    Treatment: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder
Criteria questions
Built from NCT06949423, who can take part
Record updated
15 May 2026